                               SEQUENCE LISTING

<110> ZETAGEN THERAPEUTICS, INC.
 
<120> METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS

<130> 118922-0158

<140> PCT/US2021/012445
<141> 2021-01-07

<150> 63/053,277
<151> 2020-07-17

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Tyr Gly Gly Phe Met 
1               5   


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Tyr Gly Gly Phe Leu 
1               5   


<210> 3
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(3)
<223> Aib

<400> 3
Tyr Xaa Xaa Phe Leu 
1               5   


<210> 4
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> D-Phe

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Trp

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Pen

<400> 4
Phe Cys Tyr Trp Lys Thr Xaa Thr 
1               5               


<210> 5
<211> 50
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Gln Ser Ala Leu Asp Tyr Phe Met Phe Ala Val Arg Cys Arg His Gln 
1               5                   10                  15      


Arg Arg Gln Leu Val His Phe Ala Trp Glu His Phe Arg Pro Arg Cys 
            20                  25                  30          


Lys Phe Val Trp Gly Pro Gln Asp Lys Leu Arg Arg Phe Lys Pro Ser 
        35                  40                  45              


Ser Leu 
    50  


